Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. - Wikidata - wikimedia - TriplyDB

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response.

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response.

http://www.wikidata.org/entity/Q40899986

about

Receptor for advanced glycation end products and its involvement in inflammatory diseases HMGB1-DNA complex-induced autophagy limits AIM2 inflammasome activation through RAGE HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4 A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis The Emerging Role of HMGB1 in Neuropathic Pain: A Potential Therapeutic Target for Neuroinflammation Role of advanced glycation end products in cellular signaling RAGE controls activation and anti-inflammatory signalling of protein C Stable RAGE-Heparan Sulfate Complexes Are Essential for Signal Transduction Phagocytosis of apoptotic cells in homeostasis A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis The effect of soluble RAGE on inhibition of angiotensin II-mediated atherosclerosis in apolipoprotein E deficient mice Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury RAGE-dependent activation of gene expression of superoxide dismutase and vanins by AGE-rich extracts in mice cardiac tissue and murine cardiac fibroblasts.Receptor for advanced glycation end products is detrimental during influenza A virus pneumonia.Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis.Alarmins: awaiting a clinical response RAGE signaling in inflammation and arterial aging.High-mobility group box 1 and cancer.Soluble receptor for advanced glycation end products predicts 28-day mortality in critically ill patients with sepsis The receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells.The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism.The HMGB1-RAGE axis mediates traumatic brain injury-induced pulmonary dysfunction in lung transplantation.Modulation of cell proliferation, survival and gene expression by RAGE and TLR signaling in cells of the innate and adaptive immune response: role of p38 MAPK and NF-KB.The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis.Receptor for advanced glycation endproducts (RAGE) maintains pulmonary structure and regulates the response to cigarette smoke.Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in mice Pathophysiology and treatment of septic shock in neonates.RAGE and ICAM-1 differentially control leukocyte recruitment during acute inflammation in a stimulus-dependent manner.Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging Anti-RAGE antibody ameliorates severe thermal injury in rats through regulating cellular immune function.S100B engages RAGE or bFGF/FGFR1 in myoblasts depending on its own concentration and myoblast density. Implications for muscle regeneration HMGB1 release and redox regulates autophagy and apoptosis in cancer cells.High-mobility group protein box-1 and its relevance to cerebral ischemia RAGE expression in human T cells: a link between environmental factors and adaptive immune responses.Rs1800625 in the receptor for advanced glycation end products gene predisposes to sepsis and multiple organ dysfunction syndrome in patients with major trauma.Vessel ultrasound sonographic assessment of soluble receptor for advanced glycation end products efficacy in a rat balloon injury model.

P2860

Q21285070-892666F8-DB60-4CFE-93FD-65E92899E05A Q24299935-05E4F9D7-DA86-48BA-A305-D4C0CACD19CB Q24306365-02E5FFD6-81CE-4714-945D-5818AB7E4DF6 Q24321082-3710CB7E-7C0B-4791-9806-2FDE3081486E Q24558912-828A89C4-73AC-4FD8-9AF7-B269707B9EEC Q24658378-70B8DCA6-3D19-4BAA-90D1-50724F005E02 Q26746458-68F2E56C-6305-4017-BC76-5F325ED21B25 Q27003423-600D038A-AA35-494F-A03E-5A6A9B949CCB Q27320852-2E04B821-5FBD-4743-92E9-C5E63618DE47 Q27678167-5C9D6AB1-3DFC-4A14-AC61-A456FDF78D4C Q28081044-B3443B64-EDAD-4BA7-A4BF-2C0E8551A885 Q28507626-9E675A7E-AA30-4094-8417-891C8ABFAF88 Q28535046-8760545A-CAB6-411D-8254-CD34564ED03D Q28566123-CA4EA6EF-0EF0-45F1-A8C4-B4DCF0E8ED01 Q30318035-4A4CBD48-FB9E-4FB6-8BB4-C12055361259 Q30378823-F758D929-B93F-4CE2-972F-6D5DA29794C5 Q30412055-313628FE-BFBD-49F1-A24E-D39796B765C4 Q30523797-87B6C150-4AE6-444A-BEA3-7DFF6C4B24CD Q33346824-4D851C3E-F439-4590-A998-DFEEE9FC78F3 Q33638306-317D4728-BD09-4277-8CE3-B77E251320A7 Q33709127-B317CDD7-217F-4E40-B076-B55DC21102F8 Q33709243-2C510C09-E5E6-4F14-9C9C-66AA16BA3C7F Q33743664-A29FF7E0-C435-43C6-BEA3-8CA03F12C2B6 Q33745462-7F78C16A-2749-4748-A215-5D5ECF0C4C10 Q33811066-D2C506A0-0768-4B82-9B33-0E0A2E937036 Q33822512-59734A23-14B9-4B1D-B511-D6F9B28AC4F7 Q33868755-73D4DDCE-3A92-4828-B006-AEC69C341B07 Q33873927-FB7ACC02-CE77-43F6-9B16-458C8AC85E05 Q33918403-C80C285F-E8B8-4529-83E2-818CD88B477B Q33940492-89BEA2FC-DCDF-4536-8A9E-5530C4A7DBA9 Q34039810-743D808F-E58C-40BF-AD82-D078E31D9E20 Q34067128-2B69E189-27AB-4819-A573-80F14EF18507 Q34094369-EEBFC288-977C-419B-B493-4A9CDC4776F2 Q34138346-2AA1F82E-E98B-4DE2-917A-F2A3FB30E5D9 Q34140133-E4638CB8-70D0-4FBA-BC99-4B4A2B6C50D5 Q34154797-0A949917-AD2E-4F3E-B311-51182410011C Q34170847-4E8FFCC6-231C-4DA0-8A34-37D68E4BD295 Q34235391-6F03A969-0A68-4A9E-80F9-2C8543D6DCF2 Q34457310-5F416790-BA6A-47F1-A2FB-D81598CD54E9 Q34498985-559A2402-AC38-4E7A-B966-9C843628728D

P2860

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response.

http://www.wikidata.org/entity/Q40899986

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Receptor for advanced glycatio ...... the adaptive immune response.

@en

type

label

Receptor for advanced glycatio ...... the adaptive immune response.

@en

prefLabel

Receptor for advanced glycatio ...... the adaptive immune response.

@en

P1433

Q40899986-2D12A33B-2CF9-4B89-8B4B-1FC6F0B715B0

P1476

Q40899986-36783AA7-5D13-43D9-B78E-90B4CD5D3765

P2093

Q40899986-0820F03A-D65E-4F19-9B3A-9F9817014E15

Q40899986-18CE8D13-AE42-4678-B184-7BE4F11DCAB9

Q40899986-2F3D4B66-C5AC-43D0-987B-70E60B83B5F1

Q40899986-3E010AA9-C52C-41E4-8CE1-CE97A47A6380

Q40899986-3E7D9011-9700-4FF7-A155-54F69355BCDB

Q40899986-402DF085-2840-4984-881C-6DE35862BD22

Q40899986-47725177-D18D-4D64-815E-002660060B0A

Q40899986-5B2D8473-26DB-4FEA-8FA0-C13722E09F76

Q40899986-72840DDB-D893-4E2F-B19F-07633EBAE181

Q40899986-7E3308CF-5705-48C4-93E6-7AF973A86F1E

P2860

Q40899986-08191DFB-F8B7-4DCB-A030-10FBF329F527

Q40899986-0BB8AC04-5317-4B73-87FD-D97ACA1C41D6

Q40899986-0C913414-4D5E-4F7B-965D-100A5FAD1FCC

Q40899986-109FA432-E245-423B-A06B-CB6A5F1B1F23

Q40899986-20B195BC-BAE2-4E8D-AF73-392F26A89A60

Q40899986-316DE8EF-C53E-41AE-AA5A-0EEB1A008ADF

Q40899986-358E505C-8185-455A-AA73-E74A2BFF1815

Q40899986-384D2D62-D49D-4FC7-8EE2-FEA138DC4F75

Q40899986-3A76A2C9-5F54-4893-A3D1-00238358433D

Q40899986-45AAB38D-04BA-4B8F-98DB-24832A62E0FF

P304

Q40899986-B737BE88-025D-4A43-9747-D4901AB48393

P31

Q40899986-F12E2DFA-C127-4700-87DA-6DC21AF9F4D4

P356

Q40899986-6A3DF9BD-6989-445D-AF6E-F3CED16C77A1

P407

Q40899986-E4E445AE-C7EC-4B45-A167-C0331E64C62E

P433

Q40899986-A28D3D25-D5BC-4841-9659-7BCB8CE62EA7

P478

Q40899986-F78791B1-D716-42F4-BAA2-40E8AC64549F

P577

Q40899986-0D330CCA-237C-4981-BAB3-B04F91B7CED2

P698

Q40899986-408E874A-7055-491B-9081-0B30A2B6C2F6

P921

Q40899986-1803EF9B-1A3D-4399-86E5-41134E5A0021

P932

Q40899986-5549DD69-AFAC-4254-A76E-DF54A0368052

P356

P1433

Journal of Clinical Investigation

P1476

Receptor for advanced glycatio ...... the adaptive immune response.

@en

P2093

Angelika Bierhaus

http://www.w3.org/2001/XMLSchema#string

Ann Marie Schmidt

http://www.w3.org/2001/XMLSchema#string

Bernd Arnold

http://www.w3.org/2001/XMLSchema#string

Birgit Liliensiek

http://www.w3.org/2001/XMLSchema#string

David M Stern

http://www.w3.org/2001/XMLSchema#string

Eike Martin

http://www.w3.org/2001/XMLSchema#string

Erwin Schleicher

http://www.w3.org/2001/XMLSchema#string

Florian C Kurschus

http://www.w3.org/2001/XMLSchema#string

G ünterJ Hämmerling G

http://www.w3.org/2001/XMLSchema#string

Herman-Josef Gröne

http://www.w3.org/2001/XMLSchema#string

P2860

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

HMG-1 as a late mediator of endotoxin lethality in mice

Phylogenetic perspectives in innate immunity

TREM-1 amplifies inflammation and is a crucial mediator of septic shock

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB

Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model

P304

1641-1650

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI200418704

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15173891

http://www.w3.org/2001/XMLSchema#string

P921

P932

419481

http://www.w3.org/2001/XMLSchema#string